Table 2.
Details of the cohort studies.
| Author | Age (years, months or days) | Male | Female | Blood lactate before ECMO (mmol/L) | Duration of ECMO (hours) |
|---|---|---|---|---|---|
| Beca and Butt (11) | 12y (0.2–15) | 4 | 5 | / | 137 (57–231) |
| Huang et al. (12) | 56.8y (42.7–63.6) | 39 | 13 | Survivors:5.3 Non-survivors:8.8 |
43.3 (10.2–157.5) |
| MacLaren et al. (13) | 2.5y (0.4–9) | 28 | 17 | 8.1 (5.1–12.3) | 84 (32–135) |
| MacLaren et al. (14) | 6y (2.8–12.3) | 13 | 10 | 7.8 (4.1–9.7) | 93 (43–119) |
| Park et al. (15) | 55y (44–63) | 21 | 11 | 8.9 (5.8–14.6) | 84 (43.7–115.2) |
| Rambaud et al. (16) | 30 m (1–113) | 14 | 8 | Neonatals:7.94 ± 4.92 Pediatrics: 5.2 ± 3.5 |
Neonatals:178 (24–408) Pediatrics: 141.6 (72–240) |
| Cheng et al. (17) | Unknown | / | / | 7.2 ± 5.3 | Unknown |
| Lee et al. (18) | 48y (19–67) | 6 | 2 | 12.29 (6.7–20.6) | 96(24–312) |
| Ro et al. (19) | 57.5y (48–65) | 40 | 31 | Survivors:5.8 (4.3–5.9) Non-survivors: 11.6 (7.5–15.0) |
Unknown |
| Chang et al. (20) | 7.2y ± 6.19 | 29 | 26 | / | 216 (0–2472) |
| Solé et al. (21) | Pediatrics: 3.3y (0.7–4.7) Neonatals: 1d (1–5) |
14 | 7 | 13.3 (5.6–17.8) | 84 (21–120) |
| Han et al. (22) | Survival: 45y (20–62) Death: 54y (48–61) |
14 | 9 | Survival: 4.4 (2.2–7.4) Death: 6.8 (5.5–8.9) |
Survival: 146 (125.5–167.5) Death: 159 (142.5–205.3) |
| Ruth et al. (23) | 104.5 m (17–166.75) | 4 | 10 | Survivors: 4.5 (3.8–11.7) Non-survivors: 4.8(2.0–12.4) |
147.1 (91.9–178.6) |
| Workman et al. (24) | unknown | 32 | 38 | 6.9 (3.9–10.1) | 132 (67.2–225.6) |